Home> Products> thiazolidinedione class

{ "products": [ { "_id": "6661afd366170d1ff8cb4626", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRIGLICLAGLAZE 60 ", "description": "TRIGLICLAGLAZE 60 \nGliclazide 60mg (SR) Pioglitazone 15mg and Metformin HCL 500mg(SR)\nTRIGLICLAGLAZE 60 is a combination medication designed to effectively manage type 2 diabetes mellitus by addressing multiple aspects of glucose regulation. It combines three key components: Gliclazide 60mg (SR), Pioglitazone 15mg, and Metformin HCI 500mg (SR), each contributing to improved blood sugar control through distinct mechanisms of action.\n\nGliclazide 60mg (SR): Gliclazide is a sulfonylurea medication that stimulates the pancreas to release insulin. This insulin release helps lower blood sugar levels, especially after meals, by facilitating glucose uptake into cells.\n\nPioglitazone 15mg: Pioglitazone belongs to the thiazolidinedione class and works by improving insulin sensitivity in peripheral tissues such as muscle and fat cells. Enhanced insulin sensitivity allows for better utilization of glucose, reducing insulin resistance and promoting more efficient blood sugar management.\n\nMetformin HCI 500mg (SR): Metformin is a biguanide medication that primarily works by reducing glucose production in the liver and increasing insulin sensitivity in muscle cells. It also improves glucose uptake by cells and reduces the absorption of glucose from the digestive tract.\n\nKey Benefits of TRIGLICLAGLAZE 60:\nComprehensive Glucose Control: By combining Gliclazide (SR), Pioglitazone, and Metformin HCI (SR), TRIGLICLAGLAZE 60 offers comprehensive control over blood sugar levels throughout the day.\n\nStimulates Insulin Release: Gliclazide's action in stimulating insulin release from the pancreas helps manage postprandial (after-meal) glucose spikes, contributing to overall glucose control.\n\nImproves Insulin Sensitivity: Pioglitazone enhances insulin sensitivity in tissues, leading to better glucose uptake and utilization by cells. This helps reduce insulin resistance, a common feature of type 2 diabetes.\n\nReduces Glucose Production: Metformin HCI lowers glucose production in the liver and improves insulin action in muscle cells, leading to lower fasting blood sugar levels and enhanced glucose utilization.\n\nExtended Release Formulation: The sustained-release formulations of Gliclazide and Metformin ensure a gradual and prolonged release of the medications, providing consistent blood sugar control and minimizing the risk of hypoglycemia or hyperglycemia.\n\nDosage and Administration:\nTRIGLICLAGLAZE 60 is typically taken orally once or twice daily, with meals to reduce gastrointestinal side effects.\nDosage adjustments may be required based on blood sugar levels and individual response to treatment. Follow your healthcare provider's instructions.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/trigliclaglaze-60-134279", "price": 155.0, "discountamount": 47.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "SR", "day", "risk", "meals", "Order", "liver", "EMAIL", "gradual", "fasting", "pancreas", "Enhanced", "treatment", "fat cells", "absorption", "information", "medications", "muscle cells", "Pioglitazone", "sterisonline", "Key Benefits", "hypoglycemia", "instructions", "sterispharma", "postprandial", "hyperglycemia", "CALL/WHATSAPP", "Metformin HCL", "Metformin HCI", "Administration", "glucose uptake", "TRIGLICLAGLAZE", "common feature", "glucose spikes", "insulin action", "insulin release", "Gliclazide 60mg", "digestive tract", "multiple aspects", "prolonged release", "Dosage adjustments", "peripheral tissues", "blood sugar levels", "glucose production", "insulin resistance", "glucose regulation", "distinct mechanisms", "healthcare provider", "individual response", "glucose utilization", "insulin sensitivity", "three key components", "biguanide medication", "comprehensive control", "combination medication", "sulfonylurea medication", "thiazolidinedione class", "overall glucose control", "type 2 diabetes mellitus", "Extended Release Formulation", "Comprehensive Glucose Control", "gastrointestinal side effects", "sustained-release formulations", "consistent blood sugar control", "efficient blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1485, "imageuri": "https://productimages.withfloats.com/actual/6661afd7f21358d53af3cd71.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661afd7f21358d53af3cd71.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:47:15.16Z", "updatedon": "2024-06-28T12:12:27Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trigliclaglaze-60-/1485", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRIGLICLAGLAZE 60 ", "category": "DIABETIC RANGE", "tags": [ "TRIGLICLAGLAZE 60", "Gliclazide 60mg (SR)", "Pioglitazone 15mg", "Metformin HCL 500mg(SR)", "Metformin SR 500mg uses", "Metformin SR 500 price", "Metformin SR 500 side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6661af452bed1f08484d625b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRIGLICLAGLAZE 30 ", "description": "TRIGLICLAGLAZE 30 \nGliclazide (SR) Pioglitazone and Metformin HCL (SR)\nTRIGLICLAGLAZE 30 is a combination medication formulated to manage type 2 diabetes mellitus effectively. It combines three key components: Gliclazide (SR), Pioglitazone, and Metformin HCI (SR), each targeting different aspects of glucose regulation to achieve optimal blood sugar control.\n\nGliclazide (SR): Gliclazide is a sulfonylurea medication that works by stimulating the pancreas to release insulin, which helps lower blood sugar levels. The sustained-release (SR) formulation ensures a gradual and prolonged release of the medication, providing consistent glucose-lowering effects throughout the day.\n\nPioglitazone: Pioglitazone belongs to the thiazolidinedione class of drugs and enhances insulin sensitivity in muscle and fat tissues. By improving the body's response to insulin, Pioglitazone helps reduce insulin resistance and promotes better glucose utilization by cells.\n\nMetformin HCI (SR): Metformin is a biguanide medication that works primarily by reducing glucose production in the liver and increasing insulin sensitivity in peripheral tissues. The sustained-release formulation ensures a gradual release of Metformin, minimizing gastrointestinal side effects and providing extended blood sugar control.\n\nKey Benefits of TRIGLICLAGLAZE 30:\nComprehensive Glucose Control: The combination of Gliclazide (SR), Pioglitazone, and Metformin HCI (SR) targets multiple pathways involved in glucose metabolism. This comprehensive approach helps achieve better overall blood sugar control throughout the day.\n\nStimulates Insulin Release: Gliclazide stimulates insulin secretion from the pancreas, especially after meals, which is crucial for managing postprandial (after-meal) glucose spikes.\n\nImproves Insulin Sensitivity: Pioglitazone enhances insulin sensitivity in muscle and fat tissues, allowing for better glucose uptake and utilization by cells. This action helps reduce insulin resistance, a hallmark of type 2 diabetes.\n\nReduces Hepatic Glucose Production: Metformin HCI (SR) reduces the production of glucose in the liver, helping to lower fasting blood sugar levels and prevent excessive glucose release into the bloodstream.\n\nExtended Blood Sugar Control: The sustained-release formulations of Gliclazide and Metformin ensure a gradual and prolonged release of the medications, leading to consistent blood sugar control and minimizing the risk of hypoglycemia (low blood sugar) or hyperglycemia (high blood sugar) fluctuations.\n\nDosage and Administration:\nTRIGLICLAGLAZE 30 is typically taken orally once or twice daily, as prescribed by a healthcare provider.\nThe medication is often taken with meals to reduce the risk of gastrointestinal side effects.\nDosage adjustments may be necessary based on blood sugar levels and individual response to treatment. Follow your doctor's instructions carefully.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/trigliclaglaze-30-134278", "price": 125.0, "discountamount": 37.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "risk", "drugs", "meals", "Order", "liver", "cells", "EMAIL", "doctor", "muscle", "action", "pancreas", "hallmark", "treatment", "Gliclazide", "fat tissues", "information", "medications", "bloodstream", "Pioglitazone", "sterisonline", "postprandial", "hypoglycemia", "fluctuations", "instructions", "sterispharma", "Key Benefits", "hyperglycemia", "CALL/WHATSAPP", "Metformin HCL", "Metformin HCI", "glucose uptake", "Administration", "TRIGLICLAGLAZE", "low blood sugar", "gradual release", "Insulin Release", "high blood sugar", "prolonged release", "insulin secretion", "different aspects", "multiple pathways", "peripheral tissues", "insulin resistance", "Dosage adjustments", "blood sugar levels", "glucose metabolism", "glucose regulation", "glucose utilization", "individual response", "insulin sensitivity", "healthcare provider", "meal) glucose spikes", "three key components", "biguanide medication", "combination medication", "comprehensive approach", "thiazolidinedione class", "sulfonylurea medication", "type 2 diabetes mellitus", "excessive glucose release", "Hepatic Glucose Production", "overall blood sugar control", "optimal blood sugar control", "extended blood sugar control", "gastrointestinal side effects", "sustained-release formulation", "Comprehensive Glucose Control", "consistent blood sugar control", "sustained-release (SR) formulation", "consistent glucose-lowering effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1484, "imageuri": "https://productimages.withfloats.com/actual/6661af49f21358d53af3ccec.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661af49f21358d53af3ccec.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:44:53.071Z", "updatedon": "2024-06-28T12:15:14.626Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trigliclaglaze-30-/1484", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRIGLICLAGLAZE 30 ", "category": "DIABETIC RANGE", "tags": [ "TRIGLICLAGLAZE 30", "Gliclazide (SR)", "Pioglitazone", "Metformin HCL (SR)", "Metformin SR 500mg uses", "Metformin hydrochloride 500 mg", "Metformin SR 500 side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6661aea4d91d281c30c76019", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRI GLIBEN FORTE ", "description": "TRI GLIBEN FORTE \nGlibenclamide (5mg), Metformin HCI (500mg), Pioglitazone (15mg)\nTRI GLIBEN FORTE is a combination medication containing Glibenclamide, Metformin HCI, and Pioglitazone. This combination is commonly prescribed for the management of type 2 diabetes mellitus, a condition characterized by high blood sugar levels due to insulin resistance or inadequate insulin production.\n\nGlibenclamide (5mg): Glibenclamide belongs to the sulfonylurea class of medications. It works by stimulating the pancreas to release insulin, thereby lowering blood sugar levels. Glibenclamide also helps the body use insulin more effectively.\n\nMetformin HCI (500mg): Metformin is a biguanide medication that reduces glucose production in the liver, decreases intestinal glucose absorption, and enhances insulin sensitivity in peripheral tissues. It is a first-line treatment for type 2 diabetes and helps improve overall glycemic control.\n\nPioglitazone (15mg): Pioglitazone is a thiazolidinedione medication that improves insulin sensitivity in muscle and adipose (fat) tissues. It reduces glucose production in the liver and enhances glucose uptake in peripheral tissues, leading to better blood sugar control.\n\nKey Benefits of TRI GLIBEN FORTE:\nComprehensive Glucose Control: The combination of Glibenclamide, Metformin HCI, and Pioglitazone targets multiple pathways involved in glucose metabolism, providing comprehensive control over blood sugar levels.\n\nStimulates Insulin Release: Glibenclamide stimulates insulin secretion from the pancreas, especially after meals, helping to regulate postprandial (after-meal) glucose spikes.\n\nImproves Insulin Sensitivity: Metformin and Pioglitazone improve insulin sensitivity in cells, allowing for better utilization of glucose and reducing insulin resistance.\n\nReduces Hepatic Glucose Production: Metformin and Pioglitazone both reduce the production of glucose in the liver, helping to lower fasting blood sugar levels.\n\nCardiometabolic Benefits: Pioglitazone may have additional benefits for cardiovascular health, such as reducing inflammation and improving lipid profiles.\n\nDosage and Administration:\nThe typical dosage of TRI GLIBEN FORTE is one tablet taken orally once or twice daily, as prescribed by your healthcare provider.\nIt is usually taken with meals to reduce the risk of gastrointestinal side effects.\nFollow your doctor's instructions regarding dosage adjustments based on your blood sugar levels and response to treatment.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/tri-gliben-forte-133450", "price": 74.0, "discountamount": 22.2, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "body", "risk", "Order", "500mg", "EMAIL", "liver", "meals", "cells", "muscle", "doctor", "adipose", "response", "pancreas", "condition", "management", "one tablet", "utilization", "information", "medications", "Pioglitazone", "sterispharma", "Key Benefits", "fat) tissues", "instructions", "postprandial", "inflammation", "sterisonline", "CALL/WHATSAPP", "Metformin HCI", "Glibenclamide", "Administration", "typical dosage", "glucose uptake", "lipid profiles", "Insulin Release", "TRI GLIBEN FORTE", "insulin secretion", "multiple pathways", "dosage adjustments", "glucose metabolism", "peripheral tissues", "sulfonylurea class", "insulin resistance", "blood sugar control", "healthcare provider", "insulin sensitivity", "additional benefits", "biguanide medication", "first-line treatment", "meal) glucose spikes", "cardiovascular health", "comprehensive control", "combination medication", "high blood sugar levels", "overall glycemic control", "Cardiometabolic Benefits", "type 2 diabetes mellitus", "Hepatic Glucose Production", "thiazolidinedione medication", "intestinal glucose absorption", "Comprehensive Glucose Control", "gastrointestinal side effects", "inadequate insulin production" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1483, "imageuri": "https://productimages.withfloats.com/actual/6661aea6dd39d2ccddbc8e54.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661aea6dd39d2ccddbc8e54.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:42:12.134Z", "updatedon": "2024-06-28T12:16:49.307Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//tri-gliben-forte-/1483", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRI GLIBEN FORTE ", "category": "DIABETIC RANGE", "tags": [ "TRI GLIBEN FORTE", "Glibenclamide (5mg)", "Metformin HCI (500mg)", "Pioglitazone (15mg)", "Pioglitazone 15 mg uses", "Pioglitazone side effects", "Pioglitazone uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6661adf866170d1ff8cb45d2", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TENELIGOLD PM 500 ", "description": "TENELIGOLD PM 500 \nTeneligliptin 20mg, Pioglitazone 15mg & Extended Release Metformin Hydrochloride 500mg\nTENELIGOLD PM 500 is a combination medication containing Teneligliptin, Pioglitazone, and Extended-Release Metformin Hydrochloride. It is primarily prescribed for the management of type 2 diabetes mellitus, a metabolic disorder characterized by high blood sugar levels due to insulin resistance or inadequate insulin production.\n\nTeneligliptin (20mg): Teneligliptin belongs to the dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. It works by inhibiting the DPP-4 enzyme, which enhances the levels of incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). These hormones stimulate insulin secretion and inhibit glucagon release, leading to improved glucose control after meals.\n\nPioglitazone (15mg): Pioglitazone is a thiazolidinedione medication that improves insulin sensitivity in muscle and adipose (fat) tissues. It reduces glucose production in the liver and enhances glucose uptake in peripheral tissues. This action helps lower blood sugar levels and improves overall glycemic control.\n\nExtended-Release Metformin Hydrochloride (500mg): Metformin is a biguanide medication that reduces glucose production in the liver, decreases intestinal glucose absorption, and enhances insulin sensitivity in peripheral tissues. Extended-release formulations provide a sustained release of the drug, allowing for once-daily dosing and potentially reducing gastrointestinal side effects.\n\nKey Benefits of TENELIGOLD PM 500:\nComprehensive Glycemic Control: The combination of Teneligliptin, Pioglitazone, and Extended-Release Metformin offers comprehensive control over fasting and postprandial (after-meal) blood sugar levels.\n\nImproved Insulin Sensitivity: Pioglitazone and Metformin work synergistically to improve insulin sensitivity in cells, leading to better utilization of glucose and reduced insulin resistance.\n\nIncretin Hormone Enhancement: Teneligliptin enhances the action of incretin hormones, which regulate insulin secretion and glucagon levels, resulting in improved glucose regulation after meals.\n\nReduced Side Effects: Extended-release formulations of Metformin may reduce gastrointestinal side effects compared to immediate-release formulations.\n\nDosage and Administration:\nThe typical dosage of TENELIGOLD PM 500 is one tablet taken orally once daily, preferably with meals.\nSwallow the tablet whole with a glass of water. Do not crush, chew, or split the tablet unless advised by your healthcare provider.\nFollow your doctor's instructions regarding dosage adjustments based on your medical condition and response to treatment.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/teneligold-pm-500-134300", "price": 180.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GIP", "meals", "500mg", "EMAIL", "cells", "drugs", "GLP-1", "liver", "glass", "water", "dosing", "muscle", "action", "doctor", "fasting", "response", "treatment", "management", "one tablet", "utilization", "information", "postprandial", "Pioglitazone", "Key Benefits", "fat) tissues", "sterisonline", "sterispharma", "instructions", "DPP-4 enzyme", "CALL/WHATSAPP", "TENELIGOLD PM", "Teneligliptin", "glucose uptake", "Administration", "typical dosage", "glucose control", "glucagon levels", "glucagon release", "incretin hormones", "insulin secretion", "sustained release", "medical condition", "dosage adjustments", "metabolic disorder", "glucose regulation", "peripheral tissues", "insulin resistance", "glucose production", "healthcare provider", "insulin sensitivity", "biguanide medication", "Reduced Side Effects", "comprehensive control", "combination medication", "DPP-4) inhibitor class", "dipeptidyl peptidase-4", "high blood sugar levels", "overall glycemic control", "type 2 diabetes mellitus", "meal) blood sugar levels", "Incretin Hormone Enhancement", "thiazolidinedione medication", "Extended-release formulations", "inadequate insulin production", "intestinal glucose absorption", "gastrointestinal side effects", "Comprehensive Glycemic Control", "immediate-release formulations", "Extended-Release Metformin Hydrochloride", "glucose-dependent insulinotropic peptide", "Extended Release Metformin Hydrochloride" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1481, "imageuri": "https://productimages.withfloats.com/actual/6661adfd637f8700d7ca4512.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661adfd637f8700d7ca4512.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:39:20.713Z", "updatedon": "2024-06-28T12:21:18.417Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//teneligold-pm-500-/1481", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TENELIGOLD PM 500 ", "category": "DIABETIC RANGE", "tags": [ "TENELIGOLD PM 500", "Teneligliptin 20mg", "Pioglitazone 15mg", "Metformin Hydrochloride 500mg", "Teneligliptin Tablets 20 mg uses", "Teneligliptin 20 mg + Metformin 500", "Teneligliptin 20 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6661ad3166170d1ff8cb4574", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TENELIGOLD PIO 20/15 ", "description": "TENELIGOLD PIO 20/15 \nTeneligliptin & Pioglitazone\nTENELIGOLD PIO 20/15 is a combination medication that contains Teneligliptin and Pioglitazone. It is primarily used in the management of type 2 diabetes mellitus, a condition characterized by high blood sugar levels due to insulin resistance or inadequate insulin production.\n\nTeneligliptin: Teneligliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by inhibiting the DPP-4 enzyme, which in turn enhances the levels of incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). These hormones stimulate insulin secretion and inhibit glucagon release, leading to improved glucose control after meals.\n\nPioglitazone: Pioglitazone belongs to the thiazolidinedione class of medications. It works by improving insulin sensitivity in muscle and adipose (fat) tissues, reducing glucose production in the liver, and enhancing glucose uptake in peripheral tissues. This helps lower blood sugar levels and improves overall glycemic control.\n\nBenefits of TENELIGOLD PIO 20/15:\nComprehensive Glycemic Control: The combination of Teneligliptin and Pioglitazone addresses different aspects of glucose metabolism, providing comprehensive control over fasting and postprandial (after-meal) blood sugar levels.\n\nEnhanced Insulin Sensitivity: Pioglitazone improves insulin sensitivity in cells, allowing better utilization of glucose and reducing insulin resistance.\n\nIncretin Hormone Enhancement: Teneligliptin enhances the action of incretin hormones, which regulate insulin secretion and glucagon levels, leading to better glucose regulation after meals.\n\nCardioprotective Effects: Pioglitazone has been associated with cardiovascular benefits such as improved lipid profiles and reduced risk of cardiovascular events in some patients.\n\nHow to Use TENELIGOLD PIO 20/15:\nDosage: The typical dosage is one tablet taken orally once daily, usually with meals. Your healthcare provider will determine the appropriate dosage based on your medical condition and response to treatment.\n\nAdministration: Swallow the tablet whole with a glass of water. Do not crush, chew, or split the tablet unless advised by your doctor.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/teneligold-pio-20-15-134077", "price": 149.0, "discountamount": 44.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GIP", "risk", "turn", "Order", "EMAIL", "GLP-1", "water", "glass", "meals", "cells", "liver", "action", "muscle", "doctor", "adipose", "fasting", "patients", "response", "treatment", "one tablet", "management", "information", "medications", "utilization", "Pioglitazone", "postprandial", "fat) tissues", "DPP-4 enzyme", "sterispharma", "sterisonline", "CALL/WHATSAPP", "Teneligliptin", "teneligold-pio", "glucose uptake", "lipid profiles", "typical dosage", "Administration", "TENELIGOLD PIO", "glucagon levels", "glucose control", "glucagon release", "DPP-4) inhibitor", "incretin hormones", "medical condition", "different aspects", "insulin secretion", "glucose production", "insulin resistance", "appropriate dosage", "glucose metabolism", "glucose regulation", "peripheral tissues", "healthcare provider", "cardiovascular events", "comprehensive control", "combination medication", "dipeptidyl peptidase-4", "thiazolidinedione class", "cardiovascular benefits", "high blood sugar levels", "Cardioprotective Effects", "overall glycemic control", "type 2 diabetes mellitus", "meal) blood sugar levels", "Enhanced Insulin Sensitivity", "Incretin Hormone Enhancement", "inadequate insulin production", "Comprehensive Glycemic Control", "glucose-dependent insulinotropic peptide" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1480, "imageuri": "https://productimages.withfloats.com/actual/6661ad34c749b7962dbc4345.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661ad34c749b7962dbc4345.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:36:01.592Z", "updatedon": "2024-06-28T12:39:29.014Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/teneligold-pio-20-15-/1480", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TENELIGOLD PIO 20/15 ", "category": "DIABETIC RANGE", "tags": [ "TENELIGOLD PIO 20/15", "Teneligliptin", "Pioglitazone", "Teneligliptin uses", "Teneligliptin side effects", "Teneligliptin 20mg", "Teneligliptin+Metformin", "Teneligliptin 20 mg price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6661614c870e7b20c49e4e49", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PIOSTERIS 7.5 ", "description": "PIOSTERIS 7.5 \nPioglitazone (7.5mg)\nIntroduction to PIOSTERIS 7.5\nPIOSTERIS 7.5 contains Pioglitazone 7.5mg, a medication used primarily for the management of type 2 diabetes mellitus. Pioglitazone belongs to a class of drugs known as thiazolidinediones (TZDs), which help improve blood sugar control by increasing the body's sensitivity to insulin. This medication is typically used in combination with diet and exercise to enhance glycemic control in adults with type 2 diabetes.\n\nWhat is Pioglitazone?\nOverview of Pioglitazone\nPioglitazone is an oral diabetes medication that works by making cells more sensitive to insulin, thereby allowing the body to use insulin more effectively. This helps lower blood sugar levels in patients with type 2 diabetes. Pioglitazone can be used alone or in combination with other antidiabetic medications.\n\nMechanism of Action\nInsulin Sensitization: Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPARγ) receptors, which are involved in the regulation of genes responsible for glucose and lipid metabolism. This activation increases the sensitivity of body tissues to insulin.\nGlucose Uptake: By improving insulin sensitivity, Pioglitazone enhances glucose uptake in muscle and adipose tissue and reduces hepatic glucose production, leading to lower blood sugar levels.\nBenefits of PIOSTERIS 7.5\nEffective Blood Sugar Management\nImproved Insulin Sensitivity: PIOSTERIS 7.5 helps improve the body's response to insulin, leading to better control of blood sugar levels.\nComprehensive Glycemic Control: By targeting insulin resistance, Pioglitazone provides a unique mechanism of action that complements other diabetes medications, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PIOSTERIS 7.5 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PIOSTERIS 7.5 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nLipid Profile Improvement: Pioglitazone has been shown to improve lipid profiles by lowering triglycerides and increasing HDL cholesterol levels, which can provide additional cardiovascular benefits.\nHow to Use PIOSTERIS 7.5\nDosage and Administration\nRecommended Dosage: The typical dosage of PIOSTERIS 7.5 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water. Consistency is key, so take the medication at the same time each day.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PIOSTERIS 7.5 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/piosteris-7-5-133430", "price": 59.0, "discountamount": 17.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "food", "TZDs", "diet", "lower", "cells", "class", "water", "drugs", "EMAIL", "Order", "genes", "adults", "muscle", "Action", "Support", "readings", "Overview", "patients", "same time", "PIOSTERIS", "one tablet", "full glass", "regulation", "activation", "neuropathy", "Guidelines", "retinopathy", "combination", "Consistency", "Adjustments", "information", "Optimal Use", "best results", "Reduced Risk", "sterispharma", "body tissues", "Pioglitazone", "Introduction", "sterisonline", "triglycerides", "CALL/WHATSAPP", "typical dosage", "Administration", "treatment plan", "Consistent Use", "lipid profiles", "adipose tissue", "Glucose Uptake", "Exercise Adjunct", "lipid metabolism", "unique mechanism", "PPARγ) receptors", "excellent adjunct", "insulin resistance", "thiazolidinediones", "Recommended Dosage", "insulin sensitivity", "Diabetes Management", "blood sugar control", "healthcare provider", "individual response", "Insulin Sensitization", "cardiovascular disease", "HDL cholesterol levels", "long-term complications", "lifestyle modifications", "oral diabetes medication", "type 2 diabetes mellitus", "Lipid Profile Improvement", "stable blood sugar levels", "other diabetes medications", "Additional Health Benefits", "hepatic glucose production", "Comprehensive Glycemic Control", "other antidiabetic medications", "Effective Blood Sugar Management", "additional cardiovascular benefits", "comprehensive blood sugar management", "peroxisome proliferator-activated receptor gamma" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1410, "imageuri": "https://productimages.withfloats.com/actual/6661614f7b1fc3f9dd4c82f7.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661614f7b1fc3f9dd4c82f7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T07:12:12.153Z", "updatedon": "2024-06-29T10:23:25.301Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/piosteris-7-5-/1410", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PIOSTERIS 7.5 ", "category": "DIABETIC RANGE", "tags": [ "PIOSTERIS 7.5", "Pioglitazone (7.5mg)", "pioz 7.5 price", "pioz 7.5 side effects", "tab pioz 7.5 uses", "pioz 7.5 tablet 10" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66615f8cccd5ce1a10758f47", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PIOSTERIS 30 ", "description": "PIOSTERIS 30 \nPioglitazone (30mg)\nIntroduction to PIOSTERIS 30\nPIOSTERIS 30 contains Pioglitazone 30mg, a medication used primarily for the management of type 2 diabetes mellitus. Pioglitazone belongs to a class of drugs known as thiazolidinediones (TZDs), which help improve blood sugar control by increasing the body's sensitivity to insulin. This medication is typically used in combination with diet and exercise to enhance glycemic control in adults with type 2 diabetes.\n\nWhat is Pioglitazone?\nOverview of Pioglitazone\nPioglitazone is an oral diabetes medicine that works by making cells more sensitive to insulin, thereby allowing the body to use insulin more effectively. This helps lower blood sugar levels in patients with type 2 diabetes. Pioglitazone can be used alone or in combination with other antidiabetic medications.\n\nMechanism of Action\nInsulin Sensitization: Pioglitazone works by activating peroxisome proliferator-activated receptor gamma (PPARγ) receptors, which are involved in the regulation of genes responsible for glucose and lipid metabolism. This activation increases the sensitivity of body tissues to insulin.\nGlucose Uptake: By improving insulin sensitivity, Pioglitazone enhances glucose uptake in muscle and adipose tissue and reduces hepatic glucose production, leading to lower blood sugar levels.\nBenefits of PIOSTERIS 30\nEffective Blood Sugar Management\nImproved Insulin Sensitivity: PIOSTERIS 30 helps improve the body's response to insulin, leading to better control of blood sugar levels.\nComprehensive Glycemic Control: By targeting insulin resistance, Pioglitazone provides a unique mechanism of action that complements other diabetes medications, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PIOSTERIS 30 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PIOSTERIS 30 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nLipid Profile Improvement: Pioglitazone has been shown to improve lipid profiles by lowering triglycerides and increasing HDL cholesterol levels, which can provide additional cardiovascular benefits.\nHow to Use PIOSTERIS 30\nDosage and Administration\nRecommended Dosage: The typical dosage of PIOSTERIS 30 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water. Consistency is key, so take the medication at the same time each day.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PIOSTERIS 30 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/piosteris-30-134190", "price": 95.0, "discountamount": 28.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "TZDs", "diet", "food", "cells", "genes", "water", "Order", "class", "EMAIL", "drugs", "muscle", "adults", "Action", "Support", "readings", "Overview", "patients", "same time", "PIOSTERIS", "full glass", "Guidelines", "neuropathy", "one tablet", "activation", "regulation", "Optimal Use", "combination", "information", "Adjustments", "Consistency", "retinopathy", "sterisonline", "sterispharma", "best results", "Introduction", "Reduced Risk", "body tissues", "CALL/WHATSAPP", "triglycerides", "Administration", "typical dosage", "lipid profiles", "treatment plan", "Consistent Use", "Glucose Uptake", "adipose tissue", "Exercise Adjunct", "PPARγ) receptors", "unique mechanism", "lipid metabolism", "excellent adjunct", "Pioglitazone 30mg", "insulin resistance", "thiazolidinediones", "Recommended Dosage", "insulin sensitivity", "healthcare provider", "Diabetes Management", "individual response", "blood sugar control", "Insulin Sensitization", "cardiovascular disease", "HDL cholesterol levels", "oral diabetes medicine", "lifestyle modifications", "long-term complications", "type 2 diabetes mellitus", "lower blood sugar levels", "stable blood sugar levels", "Lipid Profile Improvement", "other diabetes medications", "Additional Health Benefits", "hepatic glucose production", "Comprehensive Glycemic Control", "other antidiabetic medications", "Effective Blood Sugar Management", "additional cardiovascular benefits", "comprehensive blood sugar management", "peroxisome proliferator-activated receptor gamma" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1407, "imageuri": "https://productimages.withfloats.com/actual/66615f8f8e77bb2c715607af.png", "tileimageuri": "https://productimages.withfloats.com/tile/66615f8f8e77bb2c715607af.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T07:04:44.526Z", "updatedon": "2024-06-29T10:30:40.061Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//piosteris-30-/1407", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PIOSTERIS 30 ", "category": "DIABETIC RANGE", "tags": [ "PIOSTERIS 30", "Pioglitazone (30mg)", "Pioglitazone 30mg uses", "Pioglitazone 30mg side effects", "Pioglitazone dose", "pioglitazone price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66615b6e161afa2274ff47c8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PIOSTERIS 15 ", "description": "PIOSTERIS 15 \nPioglitazone (15mg)\nIntroduction to PIOSTERIS 15\nPIOSTERIS 15 contains Pioglitazone 15mg, a medication used primarily for the management of type 2 diabetes mellitus. Pioglitazone belongs to a class of drugs known as thiazolidinediones (TZDs), which help improve blood sugar control by increasing the body's sensitivity to insulin. This medication is typically used in combination with diet and exercise to enhance glycemic control in adults with type 2 diabetes.\n\nWhat is Pioglitazone?\nOverview of Pioglitazone\nPioglitazone is an oral diabetes medicine that works by making cells more sensitive to insulin, thereby allowing the body to use insulin more effectively. This helps lower blood sugar levels in patients with type 2 diabetes. Pioglitazone can be used alone or in combination with other antidiabetic medications.\n\nMechanism of Action\nInsulin Sensitization: Pioglitazone works by activating peroxisome proliferator-activated receptor gamma (PPARγ) receptors, which are involved in the regulation of genes responsible for glucose and lipid metabolism. This activation increases the sensitivity of body tissues to insulin.\nGlucose Uptake: By improving insulin sensitivity, Pioglitazone enhances glucose uptake in muscle and adipose tissue and reduces hepatic glucose production, leading to lower blood sugar levels.\nBenefits of PIOSTERIS 15\nEffective Blood Sugar Management\nImproved Insulin Sensitivity: PIOSTERIS 15 helps improve the body's response to insulin, leading to better control of blood sugar levels.\nComprehensive Glycemic Control: By targeting insulin resistance, Pioglitazone provides a unique mechanism of action that complements other diabetes medications, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PIOSTERIS 15 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PIOSTERIS 15 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nLipid Profile Improvement: Pioglitazone has been shown to improve lipid profiles by lowering triglycerides and increasing HDL cholesterol levels, which can provide additional cardiovascular benefits.\nHow to Use PIOSTERIS 15\nDosage and Administration\nRecommended Dosage: The typical dosage of PIOSTERIS 15 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water. Consistency is key, so take the medication at the same time each day.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PIOSTERIS 15 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/piosteris-15-133429", "price": 55.0, "discountamount": 16.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "TZDs", "diet", "food", "cells", "genes", "water", "Order", "class", "EMAIL", "drugs", "muscle", "adults", "Action", "Support", "readings", "Overview", "patients", "same time", "PIOSTERIS", "full glass", "Guidelines", "neuropathy", "one tablet", "activation", "regulation", "Optimal Use", "combination", "information", "Adjustments", "Consistency", "retinopathy", "sterisonline", "sterispharma", "best results", "Introduction", "Reduced Risk", "body tissues", "CALL/WHATSAPP", "triglycerides", "Administration", "typical dosage", "lipid profiles", "treatment plan", "Consistent Use", "Glucose Uptake", "adipose tissue", "Exercise Adjunct", "PPARγ) receptors", "unique mechanism", "lipid metabolism", "excellent adjunct", "Pioglitazone 15mg", "insulin resistance", "thiazolidinediones", "Recommended Dosage", "insulin sensitivity", "healthcare provider", "Diabetes Management", "individual response", "blood sugar control", "Insulin Sensitization", "cardiovascular disease", "HDL cholesterol levels", "oral diabetes medicine", "lifestyle modifications", "long-term complications", "type 2 diabetes mellitus", "lower blood sugar levels", "stable blood sugar levels", "Lipid Profile Improvement", "other diabetes medications", "Additional Health Benefits", "hepatic glucose production", "Comprehensive Glycemic Control", "other antidiabetic medications", "Effective Blood Sugar Management", "additional cardiovascular benefits", "comprehensive blood sugar management", "peroxisome proliferator-activated receptor gamma" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1406, "imageuri": "https://productimages.withfloats.com/actual/66615b718e77bb2c7155ff9e.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/66615b718e77bb2c7155ff9e.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T06:47:10.939Z", "updatedon": "2024-06-29T10:35:49.49Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/piosteris-15-/1406", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PIOSTERIS 15 ", "category": "DIABETIC RANGE", "tags": [ "PIOSTERIS 15", "Pioglitazone (15mg)", "Pioglitazone 15 mg uses", "Pioglitazone side effects", "Pioglitazone dose", "Pioglitazone hydrochloride" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68beb3498d01aa56733d32d9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Rivastigmine capsules IP 3 mg", "description": "PYRITIGMIN RIVA 3\nRivastigmine Capsules IP 3 mg\nPyritigmin Riva 3 is a trusted and effective formulation containing Rivastigmine Capsules IP 3 mg, designed to support patients suffering from cognitive decline associated with Alzheimer’s disease and Parkinson’s disease dementia. Manufactured with precision and care by Steris Healthcare, this medication belongs to the class of cholinesterase inhibitors and works by improving communication between nerve cells in the brain.\nAlzheimer’s disease and Parkinson’s disease dementia are progressive neurological conditions that impair memory, thinking, and overall cognitive function. While there is currently no cure, Pyritigmin Riva 3 offers symptomatic relief by enhancing mental clarity, reducing memory loss, and helping patients maintain daily functional independence for longer.\nComposition\nActive Ingredient: Rivastigmine Capsules IP 3 mg\nBrand Name: Pyritigmin Riva 3\nFormulation: Hard gelatin capsules\nUses of Rivastigmine Capsules (Pyritigmin Riva 3)\nAlzheimer’s Disease: Helps reduce memory loss, confusion, and cognitive decline.\nParkinson’s Disease Dementia: Improves focus, alertness, and reduces confusion.\nMild to Moderate Dementia: Enhances daily living activities and maintains patient independence.\nCognitive Function Support: Improves learning ability and attention span.\nHow Does Pyritigmin Riva 3 Work?\nRivastigmine, the main component of Pyritigmin Riva 3, works as a cholinesterase inhibitor. It blocks the enzymes acetylcholinesterase and butyrylcholinesterase, which break down acetylcholine—a neurotransmitter essential for memory and learning. By preventing its breakdown, Rivastigmine increases acetylcholine levels in the brain, thereby improving nerve cell communication.\nThis mechanism slows the worsening of symptoms, giving patients more time to maintain their mental functions and quality of life.\nDosage and Administration\nTypical Dose: One capsule of Pyritigmin Riva 3 (Rivastigmine 3 mg) twice daily with food, or as directed by your doctor.\nTitration: The dose may be adjusted gradually depending on tolerance and effectiveness.\nAdministration:\nSwallow the capsule whole with a glass of water.\nDo not crush or chew.\nTake at the same time each day to maintain stable drug levels.\nKey Benefits of Pyritigmin Riva 3\nImproves Memory Retention – Enhances recall ability and reduces forgetfulness.\nSlows Symptom Progression – Delays worsening of dementia symptoms.\nSupports Daily Activities – Helps patients maintain independence in dressing, eating, and communication.\nDual Action in Dementia – Effective in both Alzheimer’s disease and Parkinson’s-related dementia.\nWell-Tolerated Formulation – Designed for safe, effective long-term use.\nPossible Side Effects\nLike all medications, Pyritigmin Riva 3 may cause side effects in some individuals.\nCommon Side Effects:\nNausea\nVomiting\nLoss of appetite\nDizziness\nStomach pain\nDiarrhea\nSerious Side Effects (rare):\nSevere weight loss\nFainting or irregular heartbeat\nSeizures\nSevere allergic reaction (rash, swelling, breathing difficulty)\nPrecautions and Warnings\nInform your doctor if you have a history of heart problems, asthma, peptic ulcers, or seizures.\nUse with caution in patients with low body weight.\nAvoid alcohol, as it may worsen side effects.\nNot recommended during pregnancy or breastfeeding unless prescribed by a doctor.\nShould be used only under strict medical supervision.\nDrug Interactions\nRivastigmine may interact with:\nOther cholinergic drugs (donepezil, galantamine) – risk of side effects increases.\nAnticholinergic drugs – reduced effectiveness.\nBeta-blockers – may increase risk of slow heart rate.\nNSAIDs (like ibuprofen, aspirin) – may increase stomach irritation risk.\nAlways inform your healthcare provider about all medications you are taking.\nWhy Choose Steris Healthcare for Pyritigmin Riva 3?\nSteris Healthcare is a leading pharmaceutical company recognized for its commitment to quality, safety, and affordability. By choosing Pyritigmin Riva 3, patients and caregivers can trust:\nWHO-GMP Certified Manufacturing – Assuring international quality standards.\nStringent Quality Control – Every batch is tested for safety and efficacy.\nAffordable Pricing – Making dementia care accessible for all patients.\nPan-India Distribution – Easy availability across pharmacies and hospitals.\nPatient-Centric Approach – Focused on improving patient outcomes and quality of life.\nSteris Healthcare ensures that Pyritigmin Riva 3 (Rivastigmine Capsules IP 3 mg) is a reliable, safe, and effective solution for managing dementia-related symptoms.", "price": 250.0, "discountamount": 175.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2177, "imageuri": "https://productimages.withfloats.com/actual/68beb3505b1b9933009f8517.png", "tileimageuri": "https://productimages.withfloats.com/tile/68beb3505b1b9933009f8517.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-08T10:43:21.61Z", "updatedon": "2025-09-08T10:43:21.61Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/rivastigmine-capsules-ip-3-mg/2177", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PYRITIGMIN RIVA 3", "category": "NEUROLOGY RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }